Mechanisms and Benefits of These Supplements
These five compounds work through distinct cellular pathways—NMN and CoQ10 target mitochondrial energy production and NAD+ metabolism, resveratrol inhibits mTOR signaling, astaxanthin provides antioxidant protection, and TMG serves as a methyl donor for homocysteine metabolism.
Nicotinamide Mononucleotide (NMN)
NMN functions as a precursor for NAD+ biosynthesis, a critical coenzyme that declines with aging 1, 2. When supplemented at 250-500 mg daily, NMN increases plasma NAD+ concentrations and postprandial insulin levels 1.
The primary mechanism involves activation of SIRT1 (sirtuin 1), which then upregulates NQO-1 (NAD(P)H: quinone oxidoreductase 1), creating a protective cascade against oxidative stress 3. This pathway specifically:
- Inhibits ROS and mitochondrial ROS production
- Prevents cellular senescence by reducing p16 and p21 expression
- Protects actin cytoskeletal organization
- Improves glucose and lipid metabolism 4
Recent 2025 data from long-term administration (7 months at 400 mg/kg in mice) showed NMN attenuated high-fat-diet-induced obesity, improved skeletal muscle function, and reduced inflammatory markers (IL-1β, TNF-α) 4. The mechanism appears tissue-specific, with strongest effects in skeletal muscle and white adipose tissue involving RAB11A-mediated cellular trafficking and CPT2-linked fatty acid oxidation 5.
Important caveat: While animal studies are promising, human clinical trials show NMN increases plasma levels but evidence for functional improvements in robust older adults remains limited 2.
Resveratrol
Resveratrol acts primarily as an mTOR inhibitor, found naturally in red grape skins 6. The mTOR pathway, when overactivated by amino acids and carbohydrates, reduces autophagy—the cellular process that degrades protein aggregates implicated in Alzheimer's disease and cardiomyopathy 6.
By inhibiting mTOR, resveratrol:
- Enhances autophagy and protein aggregate clearance
- Reduces cellular aging signals
- Works synergistically with other polyphenols (EGCG from green tea, quercetin from fruits)
The compound doesn't work in isolation but affects multiple aging-related pathways beyond just mTOR 6.
Astaxanthin
While not extensively covered in the provided evidence, astaxanthin functions as a potent lipid-soluble antioxidant. Based on the context of other compounds discussed, it likely provides membrane protection and reduces oxidative stress in cellular compartments.
Trimethylglycine (TMG/Betaine)
TMG functions as a methyl group donor in the remethylation of homocysteine to methionine, particularly critical in patients with homocystinuria 7. This FDA-approved mechanism:
- Lowers plasma homocysteine concentrations in CBS deficiency, MTHFR deficiency, and cbl defects
- Increases methionine and S-adenosylmethionine (SAM) concentrations
- Shows no evidence of tolerance even after years of use
TMG occurs naturally as a metabolite of choline, present in beets, spinach, cereals, and seafood 7. The compound has demonstrated sustained efficacy without correlation between betaine plasma concentrations and homocysteine levels, suggesting a threshold effect rather than dose-dependent response 7.
Coenzyme Q10 (CoQ10)
CoQ10 serves dual roles: as an essential component of the mitochondrial electron-transport chain and as a lipid-soluble antioxidant 8, 9.
The 2022 GRADE-assessed meta-analysis of RCTs in patients with cardiometabolic disorders showed 8:
- Significant reduction in systolic blood pressure
- Dose-response relationship exists (optimal dosing requires individualized assessment)
- Deficiency is implicated in cardiometabolic disorders
CoQ10 supplementation (combined with NMN in one study) reduced ROS production, inhibited NF-κB upregulation, and reversed SIRT1 and Nrf2 suppression 10. The compound shows strongest evidence for neurodegenerative disorders like Parkinson's disease, with orphan drug status for certain encephalomyopathies 9.
Critical limitation: A 2026 study in robust older adults (400 mg daily for 12 weeks) showed increased plasma CoQ10 levels but no changes in muscle tissue levels, mitochondrial function, glucose homeostasis, or physical performance 11. This suggests tissue penetration and functional benefits may be limited in healthy aging populations.
Practical Considerations
Common pitfall: Assuming plasma level increases translate to tissue-level benefits. Both NMN and CoQ10 studies show this disconnect—plasma rises but muscle tissue concentrations and functional outcomes may not change in healthy older adults 11.
Synergistic effects: NMN and CoQ10 combined showed better protection against oxidative stress and inflammation than either alone 10. A 2025 pilot trial combining nicotinamide riboside (NMN analog) with CoQ10 in CKD patients reduced oxidative stress markers and improved cellular bioenergetics 12.
Tissue specificity matters: NMN effects vary dramatically by tissue—skeletal muscle and adipose tissue respond differently than liver 5. This explains why whole-body metabolic improvements don't always correlate with single-tissue measurements.